InnateDB Protein
|
IDBP-31935.6
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
ITM2B
|
Protein Name
|
integral membrane protein 2B
|
Synonyms
|
ABRI; BRI; BRI2; BRICD2B; E25B; E3-16; FBD; imBRI2;
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000367828
|
InnateDB Gene
|
IDBG-31933 (ITM2B)
|
Protein Structure
|
|
Function |
Plays a regulatory role in the processing of the beta- amyloid A4 precursor protein (APP) and acts as an inhibitor of the beta-amyloid peptide aggregation and fibrils deposition. Plays a role in the induction of neurite outgrowth. Functions as a protease inhibitor by blocking access of secretases to APP cleavage sites.Mature BRI2 (mBRI2) functions as a modulator of the beta-amyloid A4 precursor protein (APP) processing leading to a strong reduction in the secretion of secretase-processed beta- amyloid protein 40 and beta-amyloid protein 42.Bri23 peptide prevents aggregation of APP beta-amyloid protein 42 peptide into toxic oligomers.
|
Subcellular Localization |
Integral membrane protein 2B: Golgi apparatus membrane; Single-pass type II membrane protein. Note=Immature BRI2 (imBRI2) is cleaved by furin in the Golgi into mBRI2 and a Bri23 peptide. mBRI2 is transported to the plasma membrane and Bri23 peptide is secreted.BRI2, membrane form: Cell membrane; Single- pass type II membrane protein. Endosome membrane; Single-pass type II membrane protein. Note=Mature BRI2 (mBRI2) needs to be transported from the endoplasmic reticulum compartment to the cell membrane in order to be able to inhibit APP processing.Bri23 peptide: Secreted. Note=Detected in the cerebral spinal fluid (CSF).BRI2C, soluble form: Secreted.
|
Disease Associations |
Cerebral amyloid angiopathy, ITM2B-related 1 (CAA-ITM2B1) [MIM:176500]: A disorder characterized by amyloid deposition in the walls of cerebral blood vessels and neurodegeneration in the central nervous system. Cerebral amyloid angiopathy, non-neuritic and perivascular plaques and neurofibrillary tangles are the predominant pathological lesions. Clinical features include progressive mental deterioration, spasticity and muscular rigidity. Note=The disease is caused by mutations affecting the gene represented in this entry. A single base substitution at the stop codon of ITM2B generates a 277-residue precursor that is cleaved at the normal furin processing site to generate the ABri amyloidogenic peptide (PubMed:10391242). ABri accumulates in the brain and produces amyloid fibrils responsible for neuronal dysfunction and dementia. ABri peptide variant forms fibrils in vitro (PubMed:10526337). {ECO:0000269PubMed:10391242, ECO:0000269PubMed:10526337}.Cerebral amyloid angiopathy, ITM2B-related 2 (CAA-ITM2B2) [MIM:117300]: A disorder characterized by amyloid deposition in the walls of the blood vessels of the cerebrum, choroid plexus, cerebellum, spinal cord and retina. Plaques and neurofibrillary tangles are observed in the hippocampus. Clinical features include progressive ataxia, dementia, cataracts and deafness. Note=The disease is caused by mutations affecting the gene represented in this entry. A decamer duplication in the 3' region of ITM2B results in the production of the ADan amyloidogenic peptide (PubMed:10781099). ADan is generated by cleavage of the mutated precursor at the normal furin processing site. ADan accumulates in the brain and produces amyloid fibrils responsible for neuronal dysfunction and dementia. {ECO:0000269PubMed:10781099}.
|
Tissue Specificity |
Ubiquitous. Expressed in brain.
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 5 experimentally validated interaction(s) in this database.
Experimentally validated |
Total |
5
[view]
|
Protein-Protein |
4
[view]
|
Protein-DNA |
1
[view]
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
|
|
Molecular Function |
|
Biological Process |
GO:0007399
|
nervous system development
|
GO:0042985
|
negative regulation of amyloid precursor protein biosynthetic process
|
GO:0097192
|
extrinsic apoptotic signaling pathway in absence of ligand
|
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR007084
BRICHOS domain
|
PFAM |
PF04089
|
PRINTS |
|
PIRSF |
|
SMART |
SM01039
|
TIGRFAMs |
|
Modification |
|
SwissProt |
Q9Y287
|
PhosphoSite |
PhosphoSite-Q9Y287
|
TrEMBL |
|
UniProt Splice Variant |
|
Entrez Gene |
9445
|
UniGene |
Hs.728465
|
RefSeq |
NP_068839
|
HUGO |
HGNC:6174
|
OMIM |
603904
|
CCDS |
CCDS9409
|
HPRD |
04878
|
IMGT |
|
EMBL |
AF092128
AF136973
AF152462
AF246221
AY341247
BC000554
BC016148
BT006863
CH471075
|
GenPept |
AAD40370
AAD45280
AAF66130
AAG49434
AAH00554
AAH16148
AAP35509
AAP88930
EAX08789
EAX08790
|
|
|